Caveats in the Established Understanding of CMT1A-Reference-Cited by-同舟云学术

Caveats in the Established Understanding of CMT1A

Published:2017-06-15 Issue:8 Volume:4 Page:601-607
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Li Jun¹

Affiliation:

1. Department of Neurology; Center for Human Genetic Research; and Vanderbilt Brain Institute; Vanderbilt University School of Medicine; Nashville Tennessee

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Reference50 articles.

1. PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker;Nobbio;Brain,2014

2. Nerve conduction velocity in CMT1A: what else can we tell?;Manganelli;Eur J Neurol,2016

3. PMP22 expression in dermal nerve myelin from patients with CMT1A;Katona;Brain,2009

4. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside;Li;Brain,2005

5. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies;Lewis;Neurology,1982

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute neurologic deterioration in a patient with asymptomatic Charcot-Marie-Tooth disease following three doses of Brentuximab-Vedotin;Leukemia & Lymphoma;2024-06-03

2. Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology;Journal of the Peripheral Nervous System;2024-04-10

3. Monitoring myelin lipid composition and structure of myelinated fibers reveals a maturation delay in CMT1A;2024-03-08

4. Charcot-Marie-Tooth Disease;Reference Module in Neuroscience and Biobehavioral Psychology;2024

5. Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease;Neural Regeneration Research;2023